Anxiety epidemiology and demographics

Jump to navigation Jump to search

Anxiety Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Anxiety from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Anxiety epidemiology and demographics On the Web

Most recent articles

cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Anxiety epidemiology and demographics

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Anxiety epidemiology and demographics

CDC on Anxiety epidemiology and demographics

Anxiety epidemiology and demographics in the news

Blogs on Anxiety epidemiology and demographics

Directions to Hospitals Treating Anxiety

Risk calculators and risk factors for Anxiety epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Vindhya BellamKonda, M.B.B.S [2]

Overview

The prevalence of anxiety disorders is estimated to be 28800 per 100,000 individuals (28.8%). The female to male ratio is 3 to 2.

Epidemiology and Demographics

Prevalence

Age

Race

  • Anxiety usually more commonly affects individuals of the non-Hispanic Whites. [non Hispanic blacks] individuals are 20% less likely to develop anxiety, Hispanics are 30% less likely to experience an anxiety disorder during their life time.

Gender

References

  1. Wang PS, Lane M, Olfson M, Pincus HA, Wells KB, Kessler RC (2005). "Twelve-month use of mental health services in the United States: results from the National Comorbidity Survey Replication". Arch. Gen. Psychiatry. 62 (6): 629–40. doi:10.1001/archpsyc.62.6.629. PMID 15939840.
  2. Kessler RC, Chiu WT, Demler O, Merikangas KR, Walters EE (2005). "Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication". Arch. Gen. Psychiatry. 62 (6): 617–27. doi:10.1001/archpsyc.62.6.617. PMC 2847357. PMID 15939839.

Template:WH Template:WS